Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.

Neoplasma - 1 Jan 2008

Papadopoulou E, Tripsianis G, Anagnostopoulos K, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A

Abstract excerpt

HER-2 (human epidermal growth factor receptor-2) proto-oncogene is a member of the EGFR family and plays an important role in the regulation of cell growth, differentiation and survival and is involved in the regulation of normal breast growth and development. Alterations of HER-2 have been assoc...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to EGFR gene

Share to Polymorphism, Single Nucleotide

Share to Proto-Oncogene Mas

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 18237248

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18237248-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.PMID 18237248Read ↗

The influence of HER2 genotypes as molecular markers on breast cancer outcome.Semantic proximity Read ↗

Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.Semantic proximity Read ↗

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.Semantic proximity Read ↗

HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.Semantic proximity Read ↗

A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.Semantic proximity Read ↗

Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.Semantic proximity Read ↗

Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.Semantic proximity Read ↗

Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.Semantic proximity Read ↗

HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.Semantic proximity Read ↗

HER-2/neu gene codon 655 (Ile/Val) polymorphism in breast carcinoma patients.Semantic proximity Read ↗

HER-2/neu Ile655Val polymorphism and the risk of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.